Fresenius Medical Care working with dialysis providers in U.S. to tackle coronavirus

Fresenius Medical Care (FMC) on Wednesday said it was working with other dialysis providers to provide care in isolation for people with kidney problems in the United States who are or may be infected with coronavirus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

AbstractCoronavirus disease 2019 (COVID-19) has rapidly spread not only in China but throughout the world. Children with kidney failure (chronic kidney disease (CKD) stage 5) are at significant risk for COVID-19. In turn, a set of recommendations for the prevention and control of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 in pediatric hemodialysis (HD) centers and in home peritoneal dialysis (PD) settings have been proposed. The recommendations are based on the epidemiological features of the SARS-CoV-2 virus and COVID-19 disease, susceptibility factors, and preventive and control strateg...
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
The novel coronavirus SARS-CoV-2 (COVID-19) pandemic has crippled vascular surgery practices around the world with almost four million cases and over 260,000 deaths as of May 6, 20201. In order to preserve hospital resources including personal protective equipment and ventilators as well as to “flatten the curve” of exposure of patients and healthcare providers to COVID-19, most centers have imposed limitations on elective/scheduled surgical practices2. For vascular surgeons, this may include limiting procedures such as peripheral arterial disease with claudication, asymptomatic carot id artery disease, small a...
Source: Journal of Vascular Surgery - Category: Surgery Authors: Source Type: research
CONCLUSIONS: The main symptoms of coronavirus disease 2019 pneumonia, including fever and cough, were less common in patients on hemodialysis. Patients on hemodialysis with coronavirus disease 2019 were at higher risk of death. PMID: 32444393 [PubMed - as supplied by publisher]
Source: Clinical Journal of the American Society of Nephrology : CJASN - Category: Urology & Nephrology Authors: Tags: Clin J Am Soc Nephrol Source Type: research
While most people are familiar with the hallmark symptoms of COVID-19 by now—cough, fever, muscle aches, headaches and difficulty breathing—a new crop of medical conditions are emerging from the more than 4 million confirmed cases of the disease around the world. These include skin rashes, diarrhea, kidney abnormalities and potentially life-threatening blood clots. It’s not unusual for viruses to directly infect and affect different tissues and organs in the body, but it is a bit unusual for a primarily respiratory virus like SARS-CoV-2, which is responsible for COVID-19, to have such a wide-ranging reach...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Abstract The coronavirus outbreak is a rapidly evolving pandemic, placing unprecedented strain on health-care systems. COVID-19 presents challenges for management of children with renal diseases especially those receiving long-term immunosuppressive medications, including renal transplant recipients and those with chronic kidney disease and acute kidney injury requiring dialysis. Our preparedness for managing this vulnerable group of children is the need of the hour. The purpose of this article is to provide guidance to caregivers and health care personnel involved in management of children with renal diseases an...
Source: Indian Pediatrics - Category: Pediatrics Authors: Tags: Indian Pediatr Source Type: research
This case series describes subclinical development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in some patients and health care workers in a pediatric dialysis unit after contact with a seropositive patient.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
CONCLUSIONS: SARS-CoV-2 infection already affects a significant number of Spanish patients on RRT, mainly those on ICH, hospitalization rates are very high and mortality is high; age and the development of pneumonia are factors associated with mortality. PMID: 32389518 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
We describe for the first time the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the peritoneal waste of a patient with coronavirus disease 2019 and end-stage kidney disease on peritoneal dialysis. A 53-year-old Caucasian female affected by fibrillary glomerulonephritis and on peritoneal dialysis since November 2019 was admitted to our hospital on March 9 with fever, cough, headache, myalgia, and mild hypoxemia. Chest computed tomography showed bilateral multiple ground-glass opacities but the initial nasopharyngeal swab for SARS-CoV-2 was negative.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Letter to the Editor Source Type: research
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is a lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), and even less is available in patients on maintenance hemodialysis therapy than in the general population. In this retrospective, observational, single-center study, we analyzed the clinical course and outcomes of all maintenance hemodialysis patients hospitalized with COVID-19 from March 12th to April 10th, 2020 as confirmed by real-time polymerase chain reaction.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Editorial: Special Report Source Type: research
SARS-CoV-2-pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), even less in patients on maintenance hemodialysis (MHD) therapy than in the general population. In this retrospective observational single-center study we analyzed the clinical course and outcomes of all MHD patients hospitalized with COVID-19 from March 12th to April 10th, 2020 as confirmed by real time polymerase chain reaction.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: editorial: special report Source Type: research
More News: Coronavirus | COVID-19 | Dialysis | Health | Urology & Nephrology | USA Health